Propanc Biopharma, Inc. - PPCB
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| UBS Group AG | History | New | 182,614 | 19 | 0.0% | — | 1 | +182,614 | New | Q1 2026 | May 05, 2026 |
| JANE STREET GROUP, LLC | History | New | 143,212 | 15 | 0.0% | — | 2 | +143,212 | New | Q1 2026 | May 12, 2026 |
| Marex Group plc | History | Added to | 67,724 | 7 | 0.0% | 0.0% | 3 | +2,700 | 4.15% | Q1 2026 | May 13, 2026 |
| Virtu Financial LLC | History | New | 40,748 | 4 | 0.0% | — | 4 | +40,748 | New | Q1 2026 | May 14, 2026 |
| Sassicaia Capital Advisers LLC | History | New | 16,000 | 1 | 0.0% | — | 5 | +16,000 | New | Q1 2026 | May 13, 2026 |
| XTX Topco Ltd | History | Reduced | 12,098 | 1 | 0.0% | 0.0% | 6 | -10,028 | -45.32% | Q1 2026 | May 15, 2026 |
| TWO SIGMA SECURITIES, LLC | History | Closed out | 0 | 0 | — | 0.0% | — | -25,483 | -100.0% | Q1 2026 | May 15, 2026 |
| TWO SIGMA INVESTMENTS, LP | History | Closed out | 0 | 0 | — | 0.0% | — | -16,257 | -100.0% | Q1 2026 | May 15, 2026 |
| MORGAN STANLEY | History | Closed out | 0 | 0 | — | — | — | -1 | -100.0% | Q1 2026 | May 15, 2026 |